Acceptance and Commitment Therapy for Stem Cell Transplant

(ACTivate Trial)

Not yet recruiting at 1 trial location
AS
Overseen ByAnthony Sung, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Anthony Sung, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is a phase 2, multicenter, randomized controlled trial to test the application of Acceptance and Commitment Therapy (ACT) in HCT patients.

ACT is an evidence-based cognitive behavioral therapy intervention that emphasizes psychological flexibility and behaviors, helping transplant patients focus on actions that may help maintain adequate physical activity despite physical and emotional discomfort.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 18 and 80 years old.
Caregiver: Willingness to comply with study procedures and lifestyle considerations
Caregiver: Age 18-80
See 10 more

Exclusion Criteria

I have limits on doing intense physical activities.
I do not want to join the clinical trial.
Patient: Diagnosed with psychiatric illness or in a social situation limiting compliance
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Acceptance and Commitment Therapy (ACT) sessions to improve psychological flexibility and physical activity

4 weeks
Weekly sessions

Follow-up

Participants are monitored for changes in physical function and quality of life

12 months
Assessments at Day 30, Day 100, and Year 1

What Are the Treatments Tested in This Trial?

Interventions

  • ACT

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: ACTivate ArmExperimental Treatment1 Intervention
Group II: Education Control ArmActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Anthony Sung, MD

Lead Sponsor

Trials
1
Recruited
40+